 AUSTIN, Texas, March 30, 2021 PRNewswire -- VolitionRx Limited NYSE AMERICAN: VNRX Volition, a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, announced today the appointment, effective May 1, 2021, of Dr. Tom Butera DVM, to the position of Chief Executive Officer, Volition Veterinary Diagnostics Development LLC, assuming such role from Dr. Gaetan Michel who continues to serve as Chief Operating Officer of Volition and Chief Executive Officer of Belgian Volition. We are delighted that Tom has agreed to lead our Veterinary subsidiary. 